US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

NBY NovaBay Pharmaceuticals Inc New

0.0802

-0.0091 (-10.19%)

10 May 2024 - Cerrado

Retrasado por 15 minutos

Form D - Notice of Exempt Offering of Securities

NovaBay Pharmaceuticals (AMEX:NBY)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas NovaBay Pharmaceuticals.

NovaBay Pharmaceuticals (AMEX:NBY)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas NovaBay Pharmaceuticals.

Noticias sobre NovaBay Pharmaceuticals Inc New NBY

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
Jueves 9 de Mayo 2024 (2 días hace) • Business Wire

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
Martes 7 de Mayo 2024 (4 días hace) • Business Wire

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
Viernes 3 de Mayo 2024 (1 semana hace) • Business Wire

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
Lunes 22 de Abril 2024 (3 semanas hace) • Business Wire

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
Viernes 19 de Abril 2024 (3 semanas hace) • Business Wire

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
Miércoles 17 de Abril 2024 (3 semanas hace) • Business Wire

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
Martes 26 de Marzo 2024 (1 mes hace) • Business Wire

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
Lunes 25 de Marzo 2024 (2 meses hace) • Business Wire

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
Jueves 14 de Marzo 2024 (2 meses hace) • Business Wire

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Miércoles 14 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Martes 6 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
Martes 30 de Enero 2024 (3 meses hace) • Business Wire

Más de NovaBay Pharmaceuticals Inc New Artículos de Noticias

FalconSwaps Token

PENN Entertainment

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones